At a glance
- Originator Beijing CoSci Med-Tech
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiulcers; Gastric antisecretories; Small molecules
- Mechanism of Action Proton pump inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Gastrointestinal disorders
Most Recent Events
- 26 Jul 2016 Chemical structure information added
- 22 Jul 2016 Investigation in Gastrointestinal disorders in China (PO)